Overview
Description Levocarnitine Injection is a sterile, nonpyrogenic injectable solution containing 500 mg/mL of Levocarnitine in Sterile Water for Injection. The formulation contains benzyl alcohol 2% as a preservative, with pH adjusted to 5.0–6.5 using Hydrochloric Acid and/or Sodium Hydroxide. Each mL contains: Levocarnitine 500 mg Benzyl Alcohol 2% Sterile Water for Injection q.s.
Mechanism of Action
Description Levocarnitine Injection is a sterile, nonpyrogenic injectable solution containing 500 mg/mL of Levocarnitine in Sterile Water for Injection. The formulation contains benzyl alcohol 2% as a preservative, with pH adjusted to 5.0–6.5 using Hydrochloric Acid and/or Sodium Hydroxide. Each mL contains: Levocarnitine 500 mg Benzyl Alcohol 2% Sterile Water for Injection q.s. The solution is supplied as a multiple-dose vial for intravenous administration by a licensed healthcare professional. Levocarnitine is a naturally occurring amino acid derivative involved in fatty acid metabolism and mitochondrial energy production. This compounded sterile preparation is intended for office or clinical use only.
Common Doses
- Refer to label
Dosage
Refer to FDA label for detailed dosing.
Contraindications
- Contraindications Levocarnitine Injection is contraindicated in: Patients with known hypersensitivity to Levocarnitine, benzyl alcohol, or any component of the formulation. Neonates, premature infants, or low birth weight infants due to the risk of benzyl alcohol toxicity (“gasping syndrome”). Patients with a history of serious hypersensitivity reactions associated with Levocarnitine administration. Patients in whom administration of hypertonic intravenous solutions may result in clinically significant complications unless closely monitored by a healthcare professional.
Interactions
- No major interactions listed on the FDA label. Always consult a healthcare professional.